United States Nebulizers Market Size, Share, and COVID-19 Impact Analysis, By Type (Jet, Mesh, and Ultrasonic), By Application (COPD, Asthma, Cystic Fibrosis, and Others), and United States Nebulizers Market Insights, Industry Trend, Forecasts to 2035

United States Nebulizers Market Insights Forecasts to 2035

• The US Nebulizers Market Size Was Estimated at USD 310.7 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 5.50% from 2025 to 2035
• The US Nebulizers Market Size is Expected to Reach USD 559.9 Million by 2035

According to a research report published by Spherical Insights and Consulting, The United States Nebulizers Market Size is anticipated to reach USD 559.9 Million by 2035, growing at a CAGR of 5.50% from 2025 to 2035. The expansion of the United States nebulizers market is propelled due to the growing elderly population, the rising prevalence of chronic respiratory disorders, and the rising demand for home healthcare devices.

Market Overview

A nebuliser is a medical device that enables patients to inhale liquid medication directly into their lungs. The developing market for nebulisers is being derived primarily due to an increasing elderly population, rising prevalence and incidence of chronic respiratory disease in the USA, and a booming interest in home health devices. Moreover, the rising prevalence of chronic respiratory illnesses is one of the biggest factors driving the market's growth. Both excessive tobacco, alcohol use, poor nutrition, lack of exercise, and high obesity rates are predicted to increase the incidence and prevalence of respiratory diseases in the United States, whereby the nebuliser market will grow during the projection period. The market is also growing due to other technological advancements, such as mesh nebulisers, which provide efficient delivery of medication with lower sound levels and faster treatment times. With a race to find preventive and therapeutic strategies, the pandemic has forced the healthcare sector to take emergency measures. Patients with asthma or COPD who were aware of the possibility of COVID-19 spreading in the air expressed reluctance to utilise inhaled treatments because they are thought to be a possible source of immunosuppression and viral transmission. Nonetheless, doctors recommended that all of these patients keep taking their nebulisers and other inhaled drugs as directed. When pharmacies ran out of albuterol inhalers, nebulised albuterol was suggested as a substitute in some areas of the United States.

Report Coverage

This research report categorizes the market for the United States nebulizers market based on various segments and regions and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the United States nebulizers market. Recent market developments and competitive strategies such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the United States nebulizers market.

Driving Factors

The growth of the United States nebulizers market is boosted because nebulisers are becoming more and more popular in-home healthcare due to their easy accessibility, small size, and technical advancements that increase functionality and lower noise levels. Furthermore, third-party payers like insurance companies favour these devices since they aim to reduce costs while providing high-quality healthcare services. These elements are anticipated to support market expansion as well.

Restraining Factors

The United States nebulizers market faces obstacles due to high cost and the growing number of alternative treatment options. Patients' increasing adoption of alternative devices for treating respiratory illnesses is anticipated to compete with the need for nebulisers.

Market Segmentation

The United States Nebulizers Market Share is classified into type and application.

• The jet segment held the largest market share in 2024 and is expected to grow at a remarkable CAGR during the forecast period.

The United States nebulizers market is segmented by type into jet, mesh, and ultrasonic. Among these, the jet segment held the largest market share in 2024 and is expected to grow at a remarkable CAGR during the forecast period. The segment is driven by the ease of handling nebulizers and efficient design for drug delivery, which has made jet nebulizers the prime segment over the years. Jet nebulizers are effective in delivering formulations that cannot be delivered with dry powder inhalers and pressurized metered-dose inhalers. In addition, nebulizers are available in various designs, including jet nebulizers along with corrugated tubes, collection bags, breath-enhanced, and breath-actuated jet nebulizers, and others.

• The COPD segment held the highest revenue share in 2024 and is expected to grow at a significant CAGR during the forecast period.

Based on the application, the United States nebulizers market is segmented into COPD, asthma, cystic fibrosis, and others. Among these, the COPD segment held the highest revenue share in 2024 and is expected to grow at a significant CAGR during the forecast period. The industry is expanding because nebulisers are becoming more accessible, allowing COPD patients to utilise them outside of acute care settings. Businesses are making significant investments in cutting-edge technologies to improve the management of diseases.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the United States nebulizers market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• PARI Respiratory Equipment, Inc.
• DeVilbiss Healthcare LLC
• Briggs Healthcare
• GF HEALTH PRODUCTS, INC.
• Allied Healthcare Products, Inc.
• Teleflex Medical, Inc.
• GE Healthcare
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at the United States, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the United States nebulizers market based on the following segments:

United States Nebulizers Market, By Type

• Jet
• Mesh
• Ultrasonic

United States Nebulizers Market, By Application

• COPD
• Asthma
• Cystic Fibrosis
• Others